|
SLC25A40 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.2750999999932E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.73209999999791E-05 |
| Normal-vs-Stage2 |
2.944200E-01 |
| Normal-vs-Stage3 |
2.838300E-04 |
| Normal-vs-Stage4 |
3.024200E-04 |
| Stage1-vs-Stage2 |
2.644400E-01 |
| Stage1-vs-Stage3 |
6.992000E-01 |
| Stage1-vs-Stage4 |
4.981400E-01 |
| Stage2-vs-Stage3 |
2.277000E-01 |
| Stage2-vs-Stage4 |
1.862430E-01 |
| Stage3-vs-Stage4 |
5.347000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.90047999999443E-05 |
| Normal-vs-AfricanAmerican |
8.661200E-03 |
| Normal-vs-Asian |
3.743300E-03 |
| Caucasian-vs-AfricanAmerican |
5.289600E-01 |
| Caucasian-vs-Asian |
6.280000E-01 |
| AfricanAmerican-vs-Asian |
5.115400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.35790000027814E-07 |
| Normal-vs-Female |
2.795600E-01 |
| Male-vs-Female |
3.921300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.037080E-03 |
| Normal-vs-Extreme_Weight |
4.80660000001798E-06 |
| Normal-vs-Obese |
3.098900E-03 |
| Normal-vs-Extreme_Obese |
1.921630E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.934400E-01 |
| Normal_Weight-vs-Obese |
2.894800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.377800E-01 |
| Extreme_Weight-vs-Obese |
1.239020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.109200E-01 |
| Obese-vs-Extreme_Obese |
9.278200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.784100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.302460E-03 |
| Normal-vs-Age(61-80Yrs) |
3.75030000000498E-05 |
| Normal-vs-Age(81-100Yrs) |
1.247610E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.894200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.874000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.405000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.151800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.573820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.564200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.08029999998671E-06 |
| Normal-VS-Type2 PRCC |
7.355900E-04 |
| Normal-VS-KIRP CIMP |
9.682100E-03 |
| Normal-VS-Unclassified PRCC |
2.359600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.980000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.882000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.838500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.735200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.943430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.261600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.17240000000407E-07 |
| Normal-vs-N1 |
1.177520E-04 |
| Normal-vs-N2 |
2.211700E-02 |
| N0-vs-N1 |
4.781000E-01 |
| N0-vs-N2 |
8.614800E-01 |
| N1-vs-N2 |
8.705400E-01 |
|
|
